Decreased numeric density of succinic dehydrogenase-positive mitochondria in CA1 pyramidal neurons of 3xTg-AD mice

Rejuvenation Research

Volumn 13, Issue 2-3, 2010, Pages 144-147

  Fattoretti, P ^a,b   Balietti, M ^a,b   Casoli, T ^a   Giorgetti, B ^a   Di Stefano, G ^a   Bertoni Freddari, C ^a   Lattanzio, F ^a   Sensi, S L ^c,d  

^a INRCA   (Italy)

^b Cellular Bioenergetics Laboratory   (United States)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; SUCCINATE DEHYDROGENASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL ORGANELLE; CONTROLLED STUDY; CYTOCHEMISTRY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME ANALYSIS; HIPPOCAMPUS; MITOCHONDRIAL VOLUME DENSITY; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL;

ALZHEIMER DISEASE; ANIMALS; CA1 REGION, HIPPOCAMPAL; DISEASE MODELS, ANIMAL; MATCHED-PAIR ANALYSIS; MICE; MICE, TRANSGENIC; MITOCHONDRIA; PYRAMIDAL CELLS; SUCCINATE DEHYDROGENASE;

ANIMALIA; MUS;

EID: 77952364472     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2009.0937     Document Type: Article

References (21)

1. Wallace DC. Mitochondrial genetics: A paradigm for aging and degenerative disease? Science 1992;256:628-632.
2. Meier-Ruge W, Bertoni-Freddari C. Mitochondrial genome lesions in the pathogenesis of sporadic Alzheimer' disease. Gerontology 1999;45:289-297.
3. Bertoni-Freddari C, Fattoretti P, Giorgetti B, Solazzi M, Ba-lietti M, Meier-Ruge W. Role of mitochondrial deterioration in physiological and pathological brain aging. Gerontology 2004;50:187-192.
4. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Nalraj E, JoneP,GhanbariH,WatayaT,ShimoharnaS,ChibaS,Atwood C, Petersen R, Smith M. Oxidative damage is the earliest eventinAlzheimer's disease.JNeuropath Exper Neurol 2001; 60:759-767.
5. Blass JP, Gibson GE. The role of oxidative abnormalities in the pathophysiologyofAlzheimer's disease.Rev Neurol1991; 47:513-525.
6. Schon EA. Mitochondria In: Di Mauro S, Wallace DC (eds), Mitochondrial DNA in Human Pathology. New York: Raven Press, 1993, pp. 1-7.
7. Gutman M. Modulation of mitochondrial succinate dehy-drogenase activity, mechanism and function. Mol Cell Bio-chem 1978;20:2041-2060.
8. Fattoretti P, Bertoni-Freddari P, Casoli T, Di Stefano G, Gracciotti N. Aging-like alterations of SDH activity in Purkinje cell mitochondria of adult vitamin E-deficient rats. J Am Aging Assn 2001;24:79-84.
9. Bertoni-Freddari C, Fattoretti P, Caselli U, Paoloni R, Meier-Ruge W. Age-dependent decrease in the activity of succinic dehydrogenase in rat CA1 pyramidal cells: A quantitative cytochemical study. Mech Age Dev 1996;90:53-62.
10. Fattoretti P, Bertoni-Freddari C, Caselli U, Paoloni R, Casoli T. Quantitative cytochemistry of succinic dehydrogenase activity in rat mitochondria. Anal Quant Cytol Histol 1998;20: 521-525. (Pubitemid 29004105)
11. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Ab and synaptic dysfunction. Neuron 2003;39:409-421.
12. Bertoni-Freddari C, Sensi SL, Giorgetti B, Balietti M, Di Stefano G, Canzoniero LM, Casoli T, Fattoretti P. Decreased presence of perforated synapses in a triple-transgenic mouse model of Alzheimer's disease. Rejuvenation Res 2008;11:309-313.
13. Hajos F, Kerpel-Fronius S. Electron histochemical observation of succinic dehydrogenase activity in various parts of neurones. Exp Brain Res 1969;8:66-78.
14. Fattoretti P, Bertoni-Freddari C, Caselli U, Paoloni R, Meier-Ruge W. Impaired succinic dehydrogenase activity on rat Purkinje cell mitochondria during aging. Mech Age Dev 1998;101:175-182. (Pubitemid 28165644)
15. Coggeshall RE, Lekan HA. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 1996;364:6-15.
16. Balietti M, Fattoretti P, Giorgetti B, Casoli T, Di Stefano G, Platano D, Aicardi G, Lattanzio F, Bertoni-Freddari C. Effect of two medium chain triglycerides-supplemented diets on synaptic morphology in the cerebellar cortex of late-adult rats. Microsc Res Tech 2009 (in press).
17. Casley CS, Land JM, Sharpe MA Clark JB, Duchen MR, Canevari L. b-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol Dis 2002;10:258-267.
18. Hurai K, Aliev G, Nunomura A, Fujioka H, russel RL, At-wood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry g, Smith MA. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001;21:3017-3023.
19. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 2006;15:1437-1449.
20. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mito-chondrial function in neuronal cells. J Cell Biol 2003;161:41-54.
21. Lin MT, Beal MF. Alzhiemr's APP mangles mitochondria. Nature Med 2006;12:1241-1243.